We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Medical Properties (MPW) Ascends While Market Falls: Some Facts to Note
Read MoreHide Full Article
Medical Properties (MPW - Free Report) ended the recent trading session at $5.22, demonstrating a +1.56% change from the preceding day's closing price. The stock's change was more than the S&P 500's daily loss of 0.16%. Elsewhere, the Dow gained 0.44%, while the tech-heavy Nasdaq lost 0.76%.
Heading into today, shares of the health care real estate investment trust had gained 5.98% over the past month, outpacing the Finance sector's loss of 1.81% and the S&P 500's gain of 1.14%.
Market participants will be closely following the financial results of Medical Properties in its upcoming release. It is anticipated that the company will report an EPS of $0.16, marking stability compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $237.84 million, up 5.32% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates are projecting earnings of $0.63 per share and revenue of $945.01 million, which would represent changes of -21.25% and -5.08%, respectively, from the prior year.
Investors should also pay attention to any latest changes in analyst estimates for Medical Properties. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.58% increase. As of now, Medical Properties holds a Zacks Rank of #2 (Buy).
In terms of valuation, Medical Properties is presently being traded at a Forward P/E ratio of 8.19. This represents a discount compared to its industry average Forward P/E of 11.06.
The REIT and Equity Trust - Other industry is part of the Finance sector. With its current Zacks Industry Rank of 88, this industry ranks in the top 36% of all industries, numbering over 250.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow MPW in the coming trading sessions, be sure to utilize Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Medical Properties (MPW) Ascends While Market Falls: Some Facts to Note
Medical Properties (MPW - Free Report) ended the recent trading session at $5.22, demonstrating a +1.56% change from the preceding day's closing price. The stock's change was more than the S&P 500's daily loss of 0.16%. Elsewhere, the Dow gained 0.44%, while the tech-heavy Nasdaq lost 0.76%.
Heading into today, shares of the health care real estate investment trust had gained 5.98% over the past month, outpacing the Finance sector's loss of 1.81% and the S&P 500's gain of 1.14%.
Market participants will be closely following the financial results of Medical Properties in its upcoming release. It is anticipated that the company will report an EPS of $0.16, marking stability compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $237.84 million, up 5.32% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates are projecting earnings of $0.63 per share and revenue of $945.01 million, which would represent changes of -21.25% and -5.08%, respectively, from the prior year.
Investors should also pay attention to any latest changes in analyst estimates for Medical Properties. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.58% increase. As of now, Medical Properties holds a Zacks Rank of #2 (Buy).
In terms of valuation, Medical Properties is presently being traded at a Forward P/E ratio of 8.19. This represents a discount compared to its industry average Forward P/E of 11.06.
The REIT and Equity Trust - Other industry is part of the Finance sector. With its current Zacks Industry Rank of 88, this industry ranks in the top 36% of all industries, numbering over 250.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow MPW in the coming trading sessions, be sure to utilize Zacks.com.